Results 321 to 330 of about 2,498,630 (352)

Economic Value Added (EVA)

Controlling, 2001
openaire   +1 more source

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Economic Value Added

Revision & Regnskabsvæsen, 2003
Bak, Henrik, Elkjær-Larsen, Jens Kr.
openaire   +1 more source

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

Ca-A Cancer Journal for Clinicians, 2019
Michele Carbone, Prasad S Adusumilli, Paul Baas   +2 more
exaly  

Equitably improving outcomes for cancer survivors and supporting caregivers: A blueprint for care delivery, research, education, and policy

Ca-A Cancer Journal for Clinicians, 2019
Catherine M Alfano, Corinne R Leach, Tenbroeck G Smith   +2 more
exaly  

Decision Making in Oncology: A Review of Patient Decision Aids to Support Patient Participation

Ca-A Cancer Journal for Clinicians, 2008
Dawn Stacey, Carol L Bennett
exaly  

Direct Conversion of Methane to Value-Added Chemicals over Heterogeneous Catalysts: Challenges and Prospects

Chemical Reviews, 2017
Pierre Schwach, Xiulian Pan, Xinhe Bao
exaly  

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Nature Reviews Clinical Oncology, 2020
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué   +2 more
exaly  

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Ca-A Cancer Journal for Clinicians, 2017
Paul J Hoskins, Walter H Gotlieb
exaly